Sanofi Bets Big On IgM ‘Super Antibodies’ In Potential $6bn Cancer and Immunology Deal
IGM Biosciences Is Leader In Novel Field
The IGM Bioscience alliance gives Sanofi a differentiated approach in a crowded field of next generation antibody platforms. • Source: Alamy 
